Incidence of lenvatinib induced arterial hypertension in thyroid carcinoma: a retrospective analysis of a series of cases

Researchers from Sicor and the University of Antioquia assessed the incidence of arterial hypertension in patients with advanced thyroid cancer treated with lenvatinib. The study revealed a high frequency of treatment-induced hypertension, emphasizing the need for cardiovascular monitoring to enhance drug tolerance and clinical outcomes.